Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-05

Clinical Trial Update: Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum Disorder

View source ↗

Summary

A study is evaluating the clinical and radiological effects of ravulizumab in people with neuromyelitis optica spectrum disorder. Recruitment is ongoing at the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ravulizumab (ravulizumab)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Neuromyelitis Optica | Status: RECRUITING